REG - Fortis Frontier PLC - Update

Fortis FrontierAnnouncement

05/05/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260505:nRSE9065Ca&default-theme=true

RNS Number : 9065C  Fortis Frontier PLC  05 May 2026

 

Fortis Frontier PLC

("Fortis Frontier" or the "Company")

 

Update

 

Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly
MyHealthChecked PLC), announces that it will not be in a position to acquire
another company or business by way of a reverse takeover on or before 10 May
2026, in accordance with AIM Rule 15. As a result, the Company will be
suspended from trading on AIM pursuant to AIM Rule 40 with effect from 7:30 am
on 11 May 2026.

 

As previously reported, the Board believes that there are potentially
attractive acquisition opportunities available, and that as an AIM Rule 15
Cash Shell with surplus cash, the Company is well positioned to negotiate an
accretive transaction which could increase Shareholder value. Although the
Board is confident that a suitable acquisition can be identified within a
reasonable timescale the Directors are taking time to carefully consider and
evaluate all such approaches to ensure the most appropriate strategic option
is chosen in the best interests of the Company and its Shareholders.

 

If the Company's shares remain suspended for six months, admission of the
Company's shares will be cancelled. However, if the Company was to lose its
AIM listing under AIM Rule 41 (i.e. the Company is unable to complete an
acquisition in line with AIM Rule 15 by 11 November 2026) the Directors would
fully explore seeking an alternative listing on the Aquis Stock Exchange in
order to maintain an orderly market in the Ordinary Shares.

 

Following the recent share buybacks, and settlement of associated costs, the
Company had cash (unaudited) of approximately £3.7m as at 30 April 2026.

 

For further information contact:

 

 Fortis Frontier PLC                          www.fortisfrontierplc-ir.com (http://www.fortisfrontierplc-ir.com)
 Adam Reynolds, Executive Chairman            via Walbrook PR

 SPARK Advisory Partners Limited (NOMAD)      Tel: +44 (0)20 3368 3550
 Neil Baldwin / Dillon Wall

 Singer Capital Markets (Broker)              Tel: +44 (0)20 7496 3000
 James Serjeant / Russell Cook / Amber Higgs

 Walbrook PR Ltd (Media & IR)                 Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com
                                              (mailto:fortisfrontier@walbrookpr.com)
 Paul McManus / Alice Woodings                Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading
subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell,
as defined in the AIM Rules for Companies. On the same day the Company changed
its name to Fortis Frontier PLC. The Board is now carefully considering the
strategic options available to it in order to maximise shareholder value.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDDZLFBQELBBBF



            Copyright 2019 Regulatory News Service, all rights reserved